France launched a large-scale experiment with therapeutic cannabis in 2021. More than 3,000 patients with serious illnesses took part in the trial.
The first results of this experiment, published in 2023, show promising results. The majority of patients feel that their symptoms have improved, without unexpected side effects. No cases of drug abuse or addiction are reported. But questions still remain to be resolved, such as the price of the drug and its reimbursement status. The National Medicines Safety Agency (AN) promised on February 20 that treatments based on medical cannabis would be available in France in 2025.